AstraZeneca Hit With $3.6M Countersuit Over Royalties
U.S. drugmaker Tesaro has hit pharmaceutical giant AstraZeneca with a $3.6 million counterclaim in a dispute in England over licensing for a blockbuster cancer drug, saying it has paid too much...To view the full article, register now.
Already a subscriber? Click here to view full article